Free Trial
NASDAQ:PRPO

Precipio (PRPO) Stock Price, News & Analysis

$4.69
-0.08 (-1.68%)
(As of 07/12/2024 ET)
Today's Range
$4.31
$4.81
50-Day Range
$4.69
$6.49
52-Week Range
$4.31
$8.99
Volume
5,748 shs
Average Volume
5,418 shs
Market Capitalization
$6.89 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
PRPO stock logo

About Precipio Stock (NASDAQ:PRPO)

Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. The company is based in New Haven, Connecticut.

PRPO Stock Price History

PRPO Stock News Headlines

Billionaire opens new pathway to wealth for investors
I’ve been a financial analyst for almost three decades, but I don’t think I’ve ever seen anything quite like this before.
Precipio Inc PRPO
Billionaire opens new pathway to wealth for investors
I’ve been a financial analyst for almost three decades, but I don’t think I’ve ever seen anything quite like this before.
Precipio, Inc. (PRPO)
See More Headlines
Receive PRPO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Precipio and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/14/2024
Today
7/14/2024
Next Earnings (Estimated)
8/09/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Analytical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:PRPO
Employees
51
Year Founded
N/A

Profitability

Net Income
$-5,850,000.00
Pretax Margin
-31.00%

Debt

Sales & Book Value

Annual Sales
$15.20 million
Book Value
$10.16 per share

Miscellaneous

Free Float
1,313,000
Market Cap
$6.89 million
Optionable
No Data
Beta
1.41
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Key Executives


PRPO Stock Analysis - Frequently Asked Questions

How have PRPO shares performed this year?

Precipio's stock was trading at $6.50 at the beginning of 2024. Since then, PRPO stock has decreased by 27.8% and is now trading at $4.69.
View the best growth stocks for 2024 here
.

How were Precipio's earnings last quarter?

Precipio, Inc. (NASDAQ:PRPO) posted its quarterly earnings results on Tuesday, May, 14th. The biotechnology company reported ($1.46) earnings per share (EPS) for the quarter. The biotechnology company had revenue of $3.43 million for the quarter. Precipio had a negative trailing twelve-month return on equity of 46.12% and a negative net margin of 31.00%.

When did Precipio's stock split?

Shares of Precipio reverse split on the morning of Friday, September 22nd 2023. The 1-20 reverse split was announced on Friday, September 22nd 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, September 22nd 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

How do I buy shares of Precipio?

Shares of PRPO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Precipio own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Precipio investors own include Biocept (BIOC), Heat Biologics (HTBX), Portola Pharmaceuticals (PTLA), iBio (IBIO), Inovio Pharmaceuticals (INO), T2 Biosystems (TTOO) and VBI Vaccines (VBIV).

This page (NASDAQ:PRPO) was last updated on 7/14/2024 by MarketBeat.com Staff

From Our Partners